Thermo Fisher0046-2

The advantages and disadvantages of real-time PCR and NGS

As new technologies and methodologies emerge to address applications such as gene expression, it can get quite confusing to determine which approach is the best, whether one simply replaces the other, or do they work together to tell a more complete story? Here we try to demystify how to choose between real-time PCR (qPCR) and next-generation sequencing (NGS), or whether you really need to choose at all.

Looking to commercialize? Contact our OEM services team today ›

Real-time PCR and whole transcriptome NGS

There are two primary approaches for whole transcriptome NGS: RNA-Seq and targeted transcriptome. RNA-Seq is recommended when one or more of the following are key to your research efforts:

  • You want to detect all cellular RNA: mRNA, miRNA, tRNA, etc.
  • You want to look at transcript isoform diversity/expression
  • Novel discovery is critical, i.e. you want to identify differentially expressed genes without a priori knowledge of which targets might be impacted by your future treatment

Targeted transcriptome approaches are similar in that novel discovery is possible, although the output will be limited to the most common mRNA transcripts, generally in the range of 20,000 targets spanning most of the known transcriptome.

Where does real-time PCR fit into these workflows? Data integrity is key to gene expression experiments, therefore it is common practice to use real-time PCR both upstream and downstream of NGS. This means that we don’t live in a “real-time PCR vs. NGS” world; rather the two technologies are complementary, working together to generate trustworthy results. Upstream of NGS, it is common to use TaqMan real-time PCR to check cDNA integrity prior to NGS.

Downstream of NGS, real-time PCR continues to be the go-to method for verification of results. In cases when verification is unnecessary, it is important to note that real-time PCR is the gold-standard technology for follow-up studies involving a targeted panel of transcripts discovered during the NGS screen.

The publications below feature Ion AmpliSeq NGS accompanied by TaqMan real-time PCR for either cDNA integrity checks or verification of results.

Read our technical note showing high concordance between TaqMan Gene Expression assays, Clariom D assays, and Ion AmpliSeq Transcriptome kits.

BIOZ biomedical research articles using both Ion AmpliSeq and TaqMan technologies

99
/ 100
Bioz Rating
556 Citations
10 Images
Sort by images
Pre-treatment DNA methylome and transcriptome profiles correlate with melanoma response to anti-PD1 immunotherapy.
Cancer letters    |    2025 Mar 13    |    PubMed ID: 40089202    |    Read Article
"...DNA quantification for Ion AmpliSeq™ Library Preparation was performed using TaqMan® RNase P Detection Reagents, following the manufacturer’s instruction (ThermoFisher). DNA samples were analysed usin..." More...
Skin-Protective Performance of Alternative Stratum Corneum Formed by a Pseudo-Ceramide-Containing Steroid Lamellar Cream.
Experimental dermatology    |    2025 Mar 11    |    PubMed ID: 40066914    |    Read Article
"...Sequencing libraries were prepared using an Ion AmpliSeq Transcriptome Human Gene Expression Kit (Thermo Fisher Scientific). Briefly, RNA was reverse- transcribed using a SuperScript VILO cDNA Synthes..." More...
Retrospective nationwide survey of pediatric RDD in Japan: a high prevalence of mutations in the kinase pathway genes.
International journal of hematology    |    2025 Mar 10    |    PubMed ID: 40063331    |    Read Article
"...eviously reported in histiocytoses (Supplemental Table 1). A DNA library was prepared using Ion AmpliSeq Library Kit Plus and DNA OCAv3 (Thermo Fisher Scientific) according to the manufacturer’s proto..." More...
Quantitation of human mitochondrial DNA and whole mtGenomes sequencing of fingernail/hair shaft samples
Forensic Sciences Research    |    2025 Mar 01    |    Read Article
"...amplicons in two multiplex pools with an average targeted fragment size of 163 bp using the Ion AmpliSeq technology (Thermo Fisher Scientific). The purpose of this study was to establish this reliable..." More...
Analysis of endometrial liquid‑based cytology samples to detect somatic mutations and classify ovarian cancer
Oncology Letters    |    2025 Mar 01    |    Read Article
"... storage, the L/S ratio was above 0.2, indicating that the samples could be analyzed by the Ion AmpliSeq Cancer Hotspot Panel v2. In Japan, the proportion of germline variants in ovarian cancer is app..." More...
Tracing Emergence of SARS-CoV-2 Variants: Insights from Comprehensive Assessment Using Reverse Transcription Polymerase Chain Reaction and Whole Genome Sequencing.
Microorganisms    |    2025 Jan 31    |    PubMed ID: 40005678    |    Read Article
"...aqMan Omicron assay was used for variant typing for 122 samples. For mutation analysis, the Ion AmpliSeq SARS-CoV-2 research panel (Thermo Fisher Scientific, USA) was used during Periods A and B and e..." More...
Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1–HER3 signaling
Nature Cancer    |    2025 Jan 03    |    PubMed ID: 39753722    |    Read Article
"...rrent mutations 51 . Library preparation and sequencing were performed using multiplex PCR-based Ion Torrent AmpliSeq (Thermo Fisher Scientific) and Ion S5XL technology, as previously described 52 . ..." More...
Type III interferons induce pyroptosis in gut epithelial cells and impair mucosal repair.
Cell    |    2024 Dec 27    |    PubMed ID: 39500322    |    Read Article
"...052 Aurum Total RNA Mini Kit Bio-Rad Cat#7326820 DNesay Blood & Tissue Kit QIAGEN Cat#69504 Ion AmpliSeq Transcriptome Mouse Gene Expression Panel, Chef-Ready Kit Thermo Fisher Scientific Cat#A36412 C..." More...
IDENTIFICATION OF CLINICALLY RELEVANT GENE VARIANTS IN COLON ADENOCARCINOMA SAMPLES OF UKRAINIAN PATIENTS USING A COMPREHENSIVE CANCER PANEL: A PILOT STUDY.
Experimental oncology    |    2024 Dec 20    |    PubMed ID: 39704459    |    Read Article
"...ermo Fisher, USA). 15 ng of gDNA was taken for library preparation. DNA was amplified using Ion AmpliSeq™ Comprehensive Cancer Panel Primer Pools and AmpliSeq HiFi mix (Thermo Fisher, USA). PCR pools ..." More...
Anti-IL-4Rα aptamer reduces IL-4 signaling and formation of nasal polyps
ERJ Open Research    |    2024 Nov 14    |    Read Article
"...lyp tissues using RNeasy Kits (Qiagen). We used 1 ng of RNA for targeted whole RNA-seq with the AmpliSeq whole transcriptome on the S5 system (Thermo Fisher Scientific). Barcoded cDNA libraries were p..." More...
Characterizing the Mutational Landscape of Diffuse Large B-Cell Lymphoma in a Prospective Cohort of Mexican Patients
International Journal of Molecular Sciences    |    2024 Aug 28    |    Read Article
"...sion, diagnosis, and treatment response of lymphomas according to the literature, using the Ion AmpliSeq Chef library kit. Pools of eight samples were loaded onto Chip Ion 550 (Thermo Fisher Scientifi..." More...
Changes in mutations of cell-free DNA and liver tumor tissue in patients with advanced hepatocellular carcinoma before and after introduction of lenvatinib.
Oncology    |    2024 Jul 24    |    PubMed ID: 39047713    |    Read Article
"...) for analysis of the CTNNB1 and TP53 mutations. Specifically, according to the protocol of the AmpliSeq library, PCR was performed to amplify the required region first, the ligation next, and purific..." More...
Successive next-generation sequencing strategy for optimal fusion gene detection in non-small-cell lung cancer in clinical practice.
Pathology    |    2024 Jul 05    |    PubMed ID: 38834439    |    Read Article
"...d in parallel using targeted DNA and RNA NGS panels. DNA sequencing was performed using the Ion AmpliSeq Colon-Lung Cancer Research PanelV2 (ThermoFisher Scientific), covering >500 hotspot mutations i..." More...
LINCATRA: Two-cycle method to amplify RNA for transcriptome analysis from formalin-fixed paraffin-embedded tissue
Heliyon    |    2024 Jun 12    |    PubMed ID: 38988576    |    Read Article
"...Whole transcriptome library was prepared from both unamplified and amplified RNA using the Ion AmpliSeq human gene expression on S5 system (Thermo Fisher Scientific, USA) as previously described [ 51 ..." More...
Modelling atopic dermatitis in healthy human skin for the characterization of topical compounds.
Experimental dermatology    |    2024 May 25    |    PubMed ID: 38794814    |    Read Article
"... instruction. The internal controls were B2M and RPLP0 (Life technologies). Whole transcriptome AmpliSeq analysis was performed by reverse transcription of 10 ng total RNA in 5 μL, followed by an ampl..." More...
Quality-Assured Analysis of PIK3CA Mutations in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Tissue: A Story About the Need for Proficiency Testing for High-Quality Molecular Biomarker Reporting in Precision Medicine.
The Journal of molecular diagnostics : JMD    |    2024 Apr 30    |    PubMed ID: 38697471    |    Read Article
"...ck Biotech OncoScreen ParpMatch for Tissue Kit, HS 1 1 (100) OncoScreen Plus 1 1 (100) Illumina AmpliSeq Cancer HotSpot Panel version 2 for Illumina 1 0 (0) Qiagen GeneRead QIAact Actionable Insights ..." More...
Multi‐UniFocality (MUF), in contrast to multifocality, in thyroid lesions: Relation to lymphocytic thyroiditis
Pathology International    |    2024 Apr 01    |    PubMed ID: 38558427    |    Read Article
"...isolation system. 17 Molecular diagnostics using NGS for somatic gene variant (with a custom AmpliSeq™ Cancer Hotspot Panel; Thermo Fisher Scientific) and/or gene fusion analysis (with Archer® Fusi..." More...
Characterization and Distribution of SARS-CoV-2 Omicron Variant and its Sub-lineages in Uttarakhand using Next Generation Sequencing: A Retrospective Study
Journal of Pure and Applied Microbiology    |    2024 Mar 01    |    Read Article
"...Ion AmpliSeqTM Library kit Plus (Thermo Fisher Scientific, Waltham, Massachusetts, United States) were used for library preparation according to manufacturer’s instruction. First the samples were isol..." More...
Genomic surveillance of malaria parasites in an indigenous community in the Peruvian Amazon
ppr0812746    |    2024 Feb 29    |    Read Article
"...ected by each study site. These procedures were done up to one week before the sequencing runs. AmpliSeq Assays Pv and Pf AmpliSeq Peru library preparation was performed as previously described11,13,2..." More...
Quantitation of human mitochondrial DNA and whole mtGenomes sequencing of fingernail/hair shaft samples
Forensic Sciences Research    |    2024 Feb 22    |    Read Article
"...amplicons in two multiplex pools with an average targeted fragment size of 163 bp using the Ion AmpliSeq technology (Thermo Fisher Scientific). The purpose of this study was to establish this reliable..." More...
Mentions: 
Recency: 

Real-time PCR and Illumina targeted amplicon RNA-Seq

Illumina targeted amplicon RNA-Seq is an NGS method for measuring 12-1,200 transcripts of interest. This range of targets overlaps with what is possible with real-time PCR (Figure 1). The choice between real-time PCR and Illumina targeted amplicon RNA-Seq should take into account these factors: 

  • Historically, real-time PCR has been considered the gold standard for gene expression quantification. For this reason, real-time PCR instruments are ubiquitous, and the benchtop and data analysis workflows are familiar and straightforward. For an experiment involving 20 samples and 10 targets, with RNA samples and qPCR assays already in the freezer, all data can be generated in a few 96-well plates run across 1–2 days. The same experiment using Illumina targeted amplicon RNA-Seq would take longer, especially if an Illumina instrument was not easily accessible. Sending samples to a core facility or service provider would likely increase the sample-to-answer turnaround time. 
  • Illumina targeted amplicon RNA-Seq will also cost more money. Targeted amplicon NGS is more expensive for experiments involving less than 20 targets.
  • Lastly, sensitivity and dynamic range are often cited as strengths of Illumina targeted amplicon RNA-Seq over real-time PCR given the absolute read-counting nature of NGS. It is worthy to note that in most experimental contexts, the sensitivity and dynamic range of real-time PCR are sufficient, and achieving top-level sensitivity in Illumina targeted amplicon RNA-Seq often requires sequencing to great depths, which drives up the cost of the experiment.
sweet spots
 Click to enlarge
Figure 1. Where each technology and format is most effective based on number of targets and samples.
QPCRvsNGS graphic
Figure 2. Where real-time PCR outshines Illumina RNA-Seq

Frequently asked questions

Yes, TaqMan Gene Expression assays are available for most exon-exon junctions for all genes and species in our predesigned assay collection.  To select an assay that is variant-specific, first identify the NCBI RefSeq transcript accession number, and then use that accession number as your search term in the TaqMan Assay Search Tool.  In the resulting list of assays, choose the assay that detects only that one variant of interest.  If all available assays detect more than one RefSeq transcript, then use our Custom Assay Design Tool to attempt a variant-specific assay design. 

Yes, TaqMan Array plates are 96- and 384-well plates containing 8–384 assays (pre-spotted and dried down, all you have to do is add cDNA and master mix).  Based on the number of samples and targets needed, order just enough plates to build in technical and biological replication.  TaqMan Array cards are 384-well microfluidic cards containing 12–384 assays with the added benefit of using less master mix than conventional plates and a super-easy benchtop workflow: pipet 384-wells in 2 minutes.  TaqMan OpenArray plates are the highest-throughput option for qPCR offering the lowest price per data point.

It actually depends.  The number of samples and targets possible in a single Illumina targeted amplicon RNA-Seq run depends on the Illumina platform and chemistry.  Assuming the desired number of samples and targets can fit in a single Illumina targeted amplicon RNA-Seq run, then it will take two days from sample prep to data analysis.  If you have to outsource your Illumina NGS experiment to a core facility or service provider, then it can take days or weeks to get your results.  In contrast, the following real-time PCR experiments are possible in 1–3 days:

table targets samples
 

For Research Use Only. Not for use in diagnostic procedures.